showed that as the protein expression of REG4 in intestinal metaplasia, adenoma, carcinoma and gastritis gradually decreased according to combined immunohistochemistry and in situ hybridization on tissue microarray, indicates that REG4 may be suitable to distinguish gastric benign disease and malignant tumors (29). This evidence concerns the gene REG4 and adenoma.